BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 17985331)

  • 1. Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.
    Horrée N; Gort EH; van der Groep P; Heintz AP; Vooijs M; van Diest PJ
    J Pathol; 2008 Jan; 214(1):38-45. PubMed ID: 17985331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators.
    Horrée N; van Diest PJ; Sie-Go DM; Heintz AP
    Hum Pathol; 2007 Aug; 38(8):1232-8. PubMed ID: 17490724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
    Cohen NA; Lai SY; Ziober AF; Ziober BL
    Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
    Giatromanolaki A; Koukourakis MI; Gatter KC; Harris AL; Sivridis E
    J Clin Pathol; 2008 Feb; 61(2):217-20. PubMed ID: 17513511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
    Seeber LM; Horrée N; van der Groep P; van der Wall E; Verheijen RH; van Diest PJ
    BMC Cancer; 2010 Jun; 10():307. PubMed ID: 20565904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
    Acs G; Xu X; Chu C; Acs P; Verma A
    Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
    Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
    Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
    Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
    J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
    Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
    Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoCl2-induced HIF-1alpha expression correlates with proliferation and apoptosis in MKN-1 cells: a possible role for the PI3K/Akt pathway.
    Ardyanto TD; Osaki M; Tokuyasu N; Nagahama Y; Ito H
    Int J Oncol; 2006 Sep; 29(3):549-55. PubMed ID: 16865270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
    J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
    Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
    Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
    Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
    BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract.
    Ke HL; Wei YC; Yang SF; Li CC; Wu DC; Huang CH; Wu WJ
    Int J Urol; 2008 Mar; 15(3):200-5. PubMed ID: 18304212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions.
    Chen C; Yu Z
    Anticancer Res; 2009 Apr; 29(4):1367-72. PubMed ID: 19414389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of regulation of leptin expression in human lung adenocarcinoma cells by hypoxia inducible factor-1alpha: a preliminary study].
    Zhang YB; Fang M; He FL; Hua TF; Hu BD; Zhao H; Liu RY
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2848-53. PubMed ID: 19080496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha.
    Lim JH; Park JW; Kim MS; Park SK; Johnson RS; Chun YS
    Mol Pharmacol; 2006 Dec; 70(6):1856-65. PubMed ID: 16940187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to caspase-dependent, hypoxia-induced apoptosis is not hypoxia-inducible factor-1 alpha mediated in prostate carcinoma cells.
    Coffey RN; Morrissey C; Taylor CT; Fitzpatrick JM; Watson RW
    Cancer; 2005 Apr; 103(7):1363-74. PubMed ID: 15719438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.